{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T03:48:37Z","timestamp":1773114517038,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>At present, no well-established biomarkers were ever found to distinguish unipolar depression and bipolar disorder (BD). This study aimed to provide a clearer comparison of UA levels between BD and major depressive disorder. Peripheral UA of 119 patients with BD in acute stage (AS) and 77 in remission stage (RS), and 95 patients with UD in AS and 61 in RS were measured, so were 180 healthy controls. UA levels in BD group were higher than UD and HC groups regardless of the AS or RS, while differences in UA levels between UD group and HC group were not significant. Differences in UA levels of BD-M (bipolar mania\/hypomania) were higher than BD-D (bipolar depression) subgroups, and UA levels of BD-M and BD-D subgroups were higher than UD and HC groups. The comparison of number of participants with hyperuricemia among groups confirmed the above results. There were no significant differences in UA levels of between drug-use and drug-free\/na\u00efve subgroups. UA could distinguish BD and UD significantly both in acute and remission stage. The study suggests patients with BD had a higher level of UA than UD, especially in mania episode. UA may be a potential biomarker to distinguish BD from UD.<\/jats:p>","DOI":"10.1038\/s41598-021-97955-4","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T10:03:59Z","timestamp":1631700239000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Individuals with bipolar disorder have a higher level of uric acid than major depressive disorder: a case\u2013control study"],"prefix":"10.1038","volume":"11","author":[{"given":"Zhe","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingtan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanglei","family":"Xun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,15]]},"reference":[{"key":"97955_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jad.2014.05.043","volume":"167","author":"L Tondo","year":"2014","unstructured":"Tondo, L., Visioli, C., Preti, A. & Baldessarini, R. J. Bipolar disorders following initial depression: Modeling predictive clinical factors. J. Affect. Disord. 167, 44\u201349 (2014).","journal-title":"J. Affect. Disord."},{"key":"97955_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jad.2017.07.023","volume":"223","author":"B Liu","year":"2017","unstructured":"Liu, B. et al. Efficacy and safety of long-term antidepressant treatment for bipolar disorders\u2014A meta-analysis of randomized controlled trials. J. Affect. Disord. 223, 41\u201348 (2017).","journal-title":"J. Affect. Disord."},{"key":"97955_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1017\/s1092852917000165","volume":"22","author":"SM Stahl","year":"2017","unstructured":"Stahl, S. M. et al. Guidelines for the recognition and management of mixed depression. CNS Spectr. 22, 203\u2013219. https:\/\/doi.org\/10.1017\/s1092852917000165 (2017).","journal-title":"CNS Spectr."},{"key":"97955_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/mp.2017.188","volume":"23","author":"A Cheffer","year":"2018","unstructured":"Cheffer, A. et al. Purinergic system in psychiatric diseases. Mol. Psychiatry 23, 94\u2013106. https:\/\/doi.org\/10.1038\/mp.2017.188 (2018).","journal-title":"Mol. Psychiatry"},{"key":"97955_CR5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nrd2605","volume":"7","author":"G Burnstock","year":"2008","unstructured":"Burnstock, G. Purinergic signalling and disorders of the central nervous system. Nat. Rev. Drug Discov. 7, 575\u2013590. https:\/\/doi.org\/10.1038\/nrd2605 (2008).","journal-title":"Nat. Rev. Drug Discov."},{"key":"97955_CR6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1054\/mehy.2001.1543","volume":"58","author":"R Machado-Vieira","year":"2002","unstructured":"Machado-Vieira, R., Lara, D. R., Souza, D. O. & Kapczinski, F. Purinergic dysfunction in mania: An integrative model. Med. Hypotheses 58, 297\u2013304. https:\/\/doi.org\/10.1054\/mehy.2001.1543 (2002).","journal-title":"Med. Hypotheses"},{"key":"97955_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.pnpbp.2014.10.016","volume":"57","author":"R Ortiz","year":"2015","unstructured":"Ortiz, R., Ulrich, H., Zarate, C. A. Jr. & Machado-Vieira, R. Purinergic system dysfunction in mood disorders: A key target for developing improved therapeutics. Prog. Neuropsychopharmacol. Biol. Psychiatry 57, 117\u2013131 (2015).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"97955_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jpsychores.2016.03.014","volume":"84","author":"F Bartoli","year":"2016","unstructured":"Bartoli, F. et al. Exploring the association between bipolar disorder and uric acid: A mediation analysis. J. Psychosom Res. 84, 56\u201359. https:\/\/doi.org\/10.1016\/j.jpsychores.2016.03.014 (2016).","journal-title":"J. Psychosom Res."},{"key":"97955_CR9","first-page":"195","volume":"22","author":"D De Berardis","year":"2008","unstructured":"De Berardis, D. et al. Evaluation of plasma antioxidant levels during different phases of illness in adult patients with bipolar disorder. J. Biol. Regul. Homeostat. Agents 22, 195\u2013200 (2008).","journal-title":"J. Biol. Regul. Homeostat. Agents"},{"key":"97955_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.immbio.2012.06.003","volume":"27","author":"A Ezzaher","year":"2012","unstructured":"Ezzaher, A. et al. TBARs and non-enzymatic antioxidant parameters in Tunisian bipolar I patients. Immuno-analyse et biologie sp\u00e9cialis\u00e9e 27, 315\u2013324 (2012).","journal-title":"Immuno-analyse et biologie sp\u00e9cialis\u00e9e"},{"key":"97955_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.clinbiochem.2011.10.010","volume":"45","author":"S Wen","year":"2012","unstructured":"Wen, S. et al. Serum uric acid levels and the clinical characteristics of depression. Clin. Biochem. 45, 49\u201353. https:\/\/doi.org\/10.1016\/j.clinbiochem.2011.10.010 (2012).","journal-title":"Clin. Biochem."},{"key":"97955_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.biopsych.2013.02.024","volume":"75","author":"AR Sutin","year":"2014","unstructured":"Sutin, A. R. et al. Impulsivity is associated with uric acid: Evidence from humans and mice. Biol. Psychiatry 75, 31\u201337. https:\/\/doi.org\/10.1016\/j.biopsych.2013.02.024 (2014).","journal-title":"Biol. Psychiatry"},{"key":"97955_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.psychres.2009.07.012","volume":"180","author":"KH Chung","year":"2010","unstructured":"Chung, K. H., Huang, C. C. & Lin, H. C. Increased risk of gout among patients with bipolar disorder: A nationwide population-based study. Psychiatry Res. 180, 147\u2013150. https:\/\/doi.org\/10.1016\/j.psychres.2009.07.012 (2010).","journal-title":"Psychiatry Res."},{"key":"97955_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jad.2017.09.034","volume":"226","author":"AT Chen","year":"2017","unstructured":"Chen, A. T., Malmstrom, T. & Nasrallah, H. A. Allopurinol augmentation in acute mania: A meta-analysis of placebo-controlled trials. J. Affect. Disord. 226, 245 (2017).","journal-title":"J. Affect. Disord."},{"key":"97955_CR15","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.psychres.2014.11.038","volume":"225","author":"M Muti","year":"2015","unstructured":"Muti, M. et al. Serum uric acid levels and different phases of illness in bipolar I patients treated with lithium. Psychiatry Res. 225, 604\u2013608. https:\/\/doi.org\/10.1016\/j.psychres.2014.11.038 (2015).","journal-title":"Psychiatry Res."},{"key":"97955_CR16","first-page":"981","volume":"27","author":"S Kesebir","year":"2013","unstructured":"Kesebir, S., S\u00fcner, O., Yaylaci, E. T., Bayrak, A. & Turan, C. Increased uric acid levels in bipolar disorder: Is it trait or state?. Biol. Regul. Homeost. Agents 27, 981\u2013988 (2013).","journal-title":"Biol. Regul. Homeost. Agents"},{"key":"97955_CR17","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jad.2014.11.005","volume":"173","author":"U Albert","year":"2015","unstructured":"Albert, U. et al. Increased uric acid levels in bipolar disorder subjects during different phases of illness. J. Affect. Disord. 173, 170\u2013175. https:\/\/doi.org\/10.1016\/j.jad.2014.11.005 (2015).","journal-title":"J. Affect. Disord."},{"key":"97955_CR18","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.pnpbp.2010.02.027","volume":"34","author":"G Salvadore","year":"2010","unstructured":"Salvadore, G. et al. Increased uric acid levels in drug-naive subjects with bipolar disorder during a first manic episode. Prog. Neuropsychopharmacol. Biol. Psychiatry 34, 819\u2013821. https:\/\/doi.org\/10.1016\/j.pnpbp.2010.02.027 (2010).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"97955_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.eurpsy.2013.05.006","volume":"29","author":"C Wiener","year":"2014","unstructured":"Wiener, C. et al. Gender-based differences in oxidative stress parameters do not underlie the differences in mood disorders susceptibility between sexes. Eur. Psychiatry 29, 58\u201363. https:\/\/doi.org\/10.1016\/j.eurpsy.2013.05.006 (2014).","journal-title":"Eur. Psychiatry"},{"key":"97955_CR20","doi-asserted-by":"publisher","first-page":"229","DOI":"10.4274\/npa.y6827","volume":"51","author":"BK G\u00fcltekin","year":"2014","unstructured":"G\u00fcltekin, B. K., Kesebir, S., Kabak, S. G., Erg\u00fcn, F. F. & Tatlidil, Y. E. Are uric acid levels different from healthy subjects in bipolar affective disorder and schizophrenia?: Relationship between clinical improvement and episode severity in male patients. Noro Psikiyatri Arsivi 51, 229 (2014).","journal-title":"Noro Psikiyatri Arsivi"},{"key":"97955_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/bdi.12708","volume":"21","author":"PM Dos Santos Oliveira","year":"2019","unstructured":"Dos Santos Oliveira, P. M., Santos, V., Coroa, M., Ribeiro, J. & Madeira, N. Serum uric acid as a predictor of bipolarity in individuals with a major depressive episode. Bipolar Disord. 21, 235\u2013243. https:\/\/doi.org\/10.1111\/bdi.12708 (2019).","journal-title":"Bipolar Disord."},{"key":"97955_CR22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.pneurobio.2011.08.006","volume":"95","author":"G Burnstock","year":"2011","unstructured":"Burnstock, G., Kr\u00fcgel, U., Abbracchio, M. P. & Illes, P. Purinergic signalling: From normal behaviour to pathological brain function. Prog. Neurobiol. 95, 229\u2013274 (2011).","journal-title":"Prog. Neurobiol."},{"key":"97955_CR23","doi-asserted-by":"publisher","first-page":"896","DOI":"10.2741\/e298","volume":"3","author":"G Burnstock","year":"2011","unstructured":"Burnstock, G. Introductory overview of purinergic signalling. Front. Biosci. 3, 896\u2013900 (2011).","journal-title":"Front. Biosci."},{"key":"97955_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11302-005-0649-1","volume":"1","author":"RA Cunha","year":"2005","unstructured":"Cunha, R. A. Neuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockade. Purinergic Signal 1, 111\u2013134 (2005).","journal-title":"Purinergic Signal"},{"key":"97955_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0074-7742(05)63007-3","volume":"63","author":"BB Fredholm","year":"2005","unstructured":"Fredholm, B. B., Chen, J. F., Cunha, R. A., Svenningsson, P. & Vaugeois, J. M. Adenosine and brain function. Int. Rev. Neurobiol. 63, 191\u2013270 (2005).","journal-title":"Int. Rev. Neurobiol."},{"key":"97955_CR26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0165-6147(96)01038-3","volume":"18","author":"BB Fredholm","year":"1997","unstructured":"Fredholm, B. B. et al. Towards a revised nomenclature for P1 and P2 receptors. Trends Pharmacol. Sci. 18, 79\u201382 (1997).","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"97955_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/2040-2392-4-28","volume":"4","author":"Campbell","year":"2013","unstructured":"Campbell, et al. Rare coding variants of the adenosine A3 receptor are increased in autism: On the trail of the serotonin transporter regulome. Mol. Autism 4(1), 28 (2013).","journal-title":"Mol. Autism"},{"key":"97955_CR28","doi-asserted-by":"publisher","first-page":"11941","DOI":"10.1523\/JNEUROSCI.1183-11.2011","volume":"31","author":"SH Dennis","year":"2011","unstructured":"Dennis, S. H. et al. Oxygen\/glucose deprivation induces a reduction in synaptic AMPA receptors on hippocampal CA3 neurons mediated by mGluR1 and adenosine A3 receptors. J. Neurosci. 31, 11941\u201311952 (2011).","journal-title":"J. Neurosci."},{"key":"97955_CR29","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.neuropharm.2015.10.008","volume":"104","author":"\u00c1 Oliveira","year":"2016","unstructured":"Oliveira, \u00c1., Illes, P. & Ulrich, H. Purinergic receptors in embryonic and adult neurogenesis. Neuropharmacology 104, 272\u2013281 (2016).","journal-title":"Neuropharmacology"},{"key":"97955_CR30","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/JCP.0b013e318268391d","volume":"32","author":"R Machado-Vieira","year":"2012","unstructured":"Machado-Vieira, R. Purinergic system in the treatment of bipolar disorder: Uric acid levels as a screening test in mania. J. Clin. Psychopharmacol. 32, 735\u2013736 (2012).","journal-title":"J. Clin. Psychopharmacol."},{"key":"97955_CR31","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.3233\/JAD-2010-1330","volume":"19","author":"GL Bowman","year":"2010","unstructured":"Bowman, G. L., Shannon, J., Frei BKaye, J. A. & Quinn, J. F. Uric acid as a CNS antioxidant. J. Alzheimers Dis. 19, 1331\u20131336 (2010).","journal-title":"J. Alzheimers Dis."},{"key":"97955_CR32","doi-asserted-by":"publisher","first-page":"5523490","DOI":"10.1155\/2021\/5523490","volume":"2021","author":"Y Li","year":"2021","unstructured":"Li, Y., Yang, H., Tian, Y. & Duan, L. Factors influencing the serum uric acid in gout with cerebral infarction. Mediat. Inflamm. 2021, 5523490. https:\/\/doi.org\/10.1155\/2021\/5523490 (2021).","journal-title":"Mediat. Inflamm."},{"key":"97955_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.comppsych.2016.09.011","volume":"73","author":"F Bartoli","year":"2017","unstructured":"Bartoli, F. et al. Purinergic system dysfunctions in subjects with bipolar disorder: A comparative cross-sectional study. Compr. Psychiatry 73, 1\u20136. https:\/\/doi.org\/10.1016\/j.comppsych.2016.09.011 (2017).","journal-title":"Compr. Psychiatry"},{"key":"97955_CR34","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/S0140-6736(68)92300-3","volume":"291","author":"A Anumonye","year":"1968","unstructured":"Anumonye, A., Reading, H. W., Knight, F. & Ashcroft, G. W. Uric-acid metabolism in manic-depressive illness and during lithium therapy. Lancet 291, 1290\u20131293. https:\/\/doi.org\/10.1016\/S0140-6736(68)92300-3 (1968).","journal-title":"Lancet"},{"key":"97955_CR35","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0920-1211(91)90070-v","volume":"8","author":"HA Ring","year":"1991","unstructured":"Ring, H. A., Heller, A. J., Marshall, W. J., Johnson, A. L. & Reynolds, E. H. Plasma uric acid in patients receiving anticonvulsant monotherapy. Epilepsy Res. 8, 241\u2013244. https:\/\/doi.org\/10.1016\/0920-1211(91)90070-v (1991).","journal-title":"Epilepsy Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97955-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97955-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97955-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T15:28:14Z","timestamp":1670081294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97955-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,15]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["97955"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-97955-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,15]]},"assertion":[{"value":"9 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18307"}}